Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancerJessica Armand|eLife|2025Cited by 3
Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancerJessica Armand, Hee Won Yang|eLife|2025Cited by 0